Experimental Medicine Training Initiative
  log in
  log in
Cambridge University
Cambridge University



04/04/2017 to 04/04/2017

• Understanding the role of immunotherapies in modern drug development.
• Learning novel approaches clinical development of immunotherapies phase 1-4 (pathway to approval).
• Designing novel immunotherapies and identifying pitfalls in developing biologics.
• Key pharmacokinetic (PK) and pharmacodynamic (PD) concepts
·Application of PK/PD through research and development
·Basic PK characteristics of protein drugs
·Biomarker strategies
· Dose selection for First-in Human (FIH) clinical studies
• Understanding how to use experimental medicine to understand the human immune system & use novel statistical study designs to achieve reproducible results.


Day 1 | Tuesday 04 April 2017

Time Item
12:00 to 13:00 Registration and Lunch
13:00 to 13:05 Introduction to the day
Dr Joseph Cheriyan (CUH)
13:05 to 13:40 Journey of a biological molecule - Overview of drug development
Key Note Speaker: Dr Nic Wisniacki (GSK)
13:40 to 13:50 Q&A
13:50 to 14:30 Key technologies and challenges in pre-clinical biologics drug discovery
Dr Steve Martin (GSK). Dr Andrew Buchanan (Medimmune)
14:30 to 15:20 Biologics Interactive workshop and Q&A
Dr Steve Martin & Dr Andrew Buchanan
15:20 to 15:50 Break
15:50 to 16:30 Dose Selection for First-in-Human Studies of Biologics
Dr Paolo Vicini (MedImmune)
16:30 to 17:10 Immune Cell Responses in Participants with Type 1 Diabetes after doses of Interleukin-2 in adaptive-response clinical trials
Dr Frank Waldron-Lynch (University of Cambridge)
17:10 to 18:00 PK/PD Interactive workshop and Q&A
Dr Frank Waldron-Lynch & Dr Paolo Vicini
18:00 to 18:30 Immunopharmacology Group discussion, reflection and review
Lecturer/workshop leads
18:30 to 19:00 Close of Meeting
Depart for Trinity Hall (dinner registrants only)
19:00 to 23:00 Drinks reception followed by dinner
Trinity Hall, Cambridge


Meeting Details

Wyng Gardens Conference Centre, Cambridge, CB5 8AQ


  CPD Points

 Book Now!


Forthcoming Meetings

Cardiovascular Drug Discovery

01/11/2017 to 01/11/2017

We are pleased to announce the next event in the EMI event calendar, jointly funded and delivered with the Cardiovascular Strategic Research Initiative. Learning objectives: Understanding the changing landscape of drug discovery process and cardiovascular-specific challenges Learning ...




Copyright ©2017 Experimental Medicine Training Initiative - Cambridge University Hospitals. All rights reserved.